ESR1 and breast cancer: A high expression status of these genes correlated well with the reduced OS of BC patients as compared with that of low-expression groups for three tumor subtypes: luminal A, ER-positive LN-negative, and ER-positive tumors (Figure 6d; p-value = 0.00431, n = 560 for ER-pos tumors).